当前位置： SCI文献检索 > CANCER BIOLOGY & THERAPY期刊下所有文献 > Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells.

Autophagy limits the cytotoxic effects of the AKT inhibitor AZ7328 in human bladder cancer cells.

Abstract：

BACKGROUND:Mutations that activate the PI3K/AKT/mTOR pathway are relatively common in urothelial (bladder) cancers, but how these pathway mutations affect AKT dependency is not known. We characterized the relationship between AKT pathway mutational status and sensitivity to the effects of the selective AKT kinase inhibitor AZ7328 using a panel of 12 well-characterized human bladder cancer cell lines. METHODS:Sequenome DNA sequencing was performed to identify mutations in a panel of 12 urothelial cancer cell lines. Drug-induced proliferative inhibition and apoptosis were quantified using MTT assays and propidium iodide staining with FACS analyses. Protein activation via phosphorylation was measured by immunoblotting. Autophagy was measured by LC3 immunofluorescence and immunoblotting. RESULTS:AZ7328 inhibited proliferation and AKT substrate phosphorylation in a concentration-dependent manner but had minimal effects on apoptosis. Proliferative inhibition correlated loosely with the presence of activating PIK3CA mutations and was strengthened in combination with the mTOR inhibitor rapamycin. AZ7328 induced autophagy in some of the lines, and in the cells exposed to a combination of AZ7328 and chemical autophagy inhibitors apoptosis was induced. CONCLUSIONS:The cytostatic effects of AZ7328 correlate with PIK3CA mutations and are greatly enhanced by dual pathway inhibition using an mTOR inhibitor. Furthermore, AZ7328 can interact with autophagy inhibitors to induce apoptosis in some cell lines. Overall, our results support the further evaluation of combinations of PI3K/AKT/mTOR pathway and autophagy inhibitors in pre-clinical in vivo models and ultimately in patients with PIK3CA mutant bladder cancers.

journal_name

Cancer Biol Ther

journal_title

Cancer biology & therapy

authors

Dickstein RJ,Nitti G,Dinney CP,Davies BR,Kamat AM,McConkey DJ

doi

10.4161/cbt.21793

subject

Has Abstract

pub_date

2012-11-01 00:00:00

pages

1325-38

issue

13

eissn

1538-4047

issn

1555-8576

pii

21793

journal_volume

13

pub_type

杂志文章

相关文献

CANCER BIOLOGY & THERAPY文献大全
  • Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.

    abstract：OBJECTIVES:Due to the absence of reliable and accurate biomarkers for the early detection of liver malignancy, circulating microRNAs have recently emerged as great candidates for prompt cancer identification. Therefore, the aim of this study was to investigate the potential of liver-specific circulating microRNAs as an...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2018.1423922

    authors： Mourad L,El-Ahwany E,Zoheiry M,Abu-Taleb H,Hassan M,Ouf A,Rahim AA,Hassanien M,Zada S

    更新日期：2018-05-04 00:00:00

  • Anticancer imidazoacridinone C-1311 inhibits hypoxia-inducible factor-1α (HIF-1α), vascular endothelial growth factor (VEGF) and angiogenesis.

    abstract：:Antitumor imidazoacridinone C-1311 is a DNA-reactive topoisomerase II and FLT3 receptor tyrosine kinase inhibitor. Here, we demonstrate the mechanism of C-1311 inhibitory action on novel targets: hypoxia-inducible factor-1α (HIF-1α), vascular-endothelial growth factor (VEGF), and angiogenesis. In a cell-free system, C...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.12.7.15980

    authors： Paradziej-Łukowicz J,Skwarska A,Peszyńska-Sularz G,Brillowska-Dąbrowska A,Konopa J

    更新日期：2011-10-01 00:00:00

  • The biology of hormone refractory breast and prostate cancer: An NCI workshop report.

    abstract：:The molecular regulation of growth and progression of hormone refractory breast and prostate cancers remains challenging. The Division of Cancer Biology, NCI organized a small "think tank" style workshop and invited scientists in relevant areas to assess the state of science on the biology of hormone refractory tumors...

    journal_title：Cancer biology & therapy

    pub_type：

    doi：10.4161/cbt.8.21.9918

    authors： Mohla S,Stearns V,Sathyamoorthy N,Rosenfeld MG,Nelson P

    更新日期：2009-11-01 00:00:00

  • New paradigms for cancer drug discovery.

    abstract：:Discovering drugs has never been an easy task. Traditionally, this task has exclusively been undertaken by large pharmaceutical companies that recovered their high research and development costs by selling expensive medications. Despite the huge amount of time and effort devoted towards drug discovery over the last de...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.2.4.448

    authors： Sager JA,Lengauer C

    更新日期：2003-07-01 00:00:00

  • IDO inhibits T-cell function through suppressing Vav1 expression and activation.

    abstract：PURPOSE:Indoleamine 2,3-dioxygenase (IDO), a tryptophan catabolic enzyme, plays an important role in immune escape through suppressing T-cell function. Since Vav1 signaling pathway regulates T cell homeostasis, this study was designed to test the hypothesis that IDO induces T-cell immunosuppression through inhibiting V...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.8.14.8882

    authors： Li R,Wei F,Yu J,Li H,Ren X,Hao X

    更新日期：2009-07-01 00:00:00

  • The signal pathways in azoxymethane-induced colon cancer and preventive implications.

    abstract：:Colon cancer is the third most common cancer and third most common cause of cancer-related death in the USA according to 2008 American Cancer Society statistics. The carcinogenesis of colon cancer has been associated with both genetics and environmental factors. It has been found that several signal pathways, includin...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.8.14.8983

    authors： Chen J,Huang XF

    更新日期：2009-07-01 00:00:00

  • A useful agent for chemoprevention of hepatocellular carcinoma?

    abstract：:Hepatocellular carcinoma (HCC) is a major health problem worldwide, involving more than 620,000 new cases yearly, with chronic HBV and HCV infection being the most common causes. Because most patients are diagnosed in an advanced state which is usually not amenable to curative therapy, prevention should be the main fo...

    journal_title：Cancer biology & therapy

    pub_type： 评论,杂志文章

    doi：10.4161/cbt.5.12.3737

    authors： Liu Q,Song Y,Zhou Y,Qiao L

    更新日期：2006-12-01 00:00:00

  • Development of a biomimetic peptide derived from collagen IV with anti-angiogenic activity in breast cancer.

    abstract：:Breast cancer is one of the most commonly diagnosed malignancies in women. Despite the remarkable success of mammography screening and use of adjuvant systemic therapy, it is estimated that approximately 200,000 new diagnoses will be made this year and 40,000 deaths will occur due to this disease (American Cancer Soci...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.12.9.17677

    authors： Rosca EV,Koskimaki JE,Pandey NB,Wolff AC,Popel AS

    更新日期：2011-11-01 00:00:00

  • Growth inhibitory effects of gastric cancer cells with an increase in S phase and alkaline phosphatase activity repression by aloe-emodin.

    abstract：:Aloe-emodin is a novel active compound found in the root and rhizome of Rheum palmatum. To investigate the effects and mechanisms of aloe-emodin on human gastric cancer, MGC-803 cells were treated with 2.5, 5, 10, 20 and 40 microM aloe-emodin for 1-5 d. The results showed that aloe-emodin inhibited the growth of cance...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.6.1.3553

    authors： Guo J,Xiao B,Zhang S,Liu D,Liao Y,Sun Q

    更新日期：2007-01-01 00:00:00

  • Selectively oncolytic mutant of HSV-1 lyses HeLa cells mediated by Ras/RTN3.

    abstract：:The selectively oncolytic mtHSV, a HSV icp34.5 mutant with lacz gene insertion, was proved that it was targeted for treating tumors but not other organs, however, its oncolytic mechanism is under confirmation. The results showed that HeLa cells could be lysed efficiently by mtHSV in vitro. In the flow cytometry and We...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.6.2.3628

    authors： Su Y,Zhu H,Xiao W,Xu Q,Zhu L,Zhang X,Wan Q,Zhou S,Du E,Xu H,Yao L,Lv S,Hu B,Liu Y,Qi Y

    更新日期：2007-02-01 00:00:00

  • SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK).

    abstract：:AMPK has been termed the fuel sensor of mammalian cells because it directly responds to the depletion of the fuel molecule ATP. In previous work, we found that AMPK is strongly activated by tumor-like hypoxia and glucose deprivation, independently of the oxygen response system associated with HIF-1. We also observed h...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.10.1.12162

    authors： Laderoute KR,Calaoagan JM,Madrid PB,Klon AE,Ehrlich PJ

    更新日期：2010-07-01 00:00:00

  • Randomized discontinuation trial of sorafenib (BAY 43-9006).

    abstract：:With the increasing interest in development of cytostatic anticancer drugs, the randomized discontinuation trial (RDT) design has been proved to be useful in the evaluation of their clinical activity. In the June 1, 2006 issue of the Journal of Clinical Oncology, a study by Ratain et al. uses RDT in a phase-II placebo...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,随机对照试验

    doi：10.4161/cbt.5.10.3290

    authors： Jain L,Venitz J,Figg WD

    更新日期：2006-10-01 00:00:00

  • Peroxisome proliferator-activated receptor gamma in bladder cancer: a promising therapeutic target.

    abstract：:Peroxisome Proliferator-Activated Receptors (PPARs) are ligand-activated intracellular transcription factors, members of the nuclear hormone receptor superfamily. The PPAR subfamily consist of three subtypes encoded by distinct genes denoted PPARalpha, PPARbeta/delta, and PPARgamma. The peroxisome proliferator-activat...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.8.7.7853

    authors： Mansure JJ,Nassim R,Kassouf W

    更新日期：2009-04-01 00:00:00

  • Targeting hypoxia and angiogenesis through HIF-1alpha inhibition.

    abstract：:Hypoxia is an important phenomenon in the tumor microenvironment. Hypoxic tumors are more aggressive and resistant to anti-neoplastic treatments. HIF-1alpha plays a major role in the response of tumors to hypoxia, and it is mainly responsible for the "angiogenic switch". HIF-1alpha contributes to tumor aggressiveness,...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.4.10.2195

    authors： Diaz-Gonzalez JA,Russell J,Rouzaut A,Gil-Bazo I,Montuenga L

    更新日期：2005-10-01 00:00:00

  • 17beta-estradiol and tamoxifen stimulate rapid and transient ERK activationin MCF-7 cells via distinct signaling mechanisms.

    abstract：:Traditionally, estrogen signaling was thought to be mediated strictly through genomic pathways. Recently, however, it has been demonstrated that estrogen stimulation of cells leads to rapid nongenomic effects including ERK activation. While the precise mechanism of this action is still under investigation, it is known...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.5.12.3378

    authors： Visram H,Greer PA

    更新日期：2006-12-01 00:00:00

  • Invasive stratified mucin-producing carcinoma: a clinicopathological analysis of three cases.

    abstract：:Objective: To investigate the clinicopathologic features and immunophenotype of invasive-stratified mucin-producing carcinoma (ISMC). Methods: We retrospectively analyzed three patients who underwent surgery for pathologically confirmed ISMC from January 2017 to December 2017 in Anyang Tumor Hospital. The pathological...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2019.1647054

    authors： Lei R

    更新日期：2019-01-01 00:00:00

  • Cancer stem cell and cancer stemloids: from biology to therapy.

    abstract：:It has become a cliché that cancer therapy fails because it does not target rare cancer stem cells (CSCs). Here we are discuss that this is not how therapy fails and not any cancer cell with stem-like properties is CSC. Paradoxically, CSCs must be resting to explain their resistance to therapy yet must be cycling to e...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.6.11.5167

    authors： Blagosklonny MV

    更新日期：2007-11-01 00:00:00

  • Increased frequency of circulating invariant natural killer T cells in malignant pleural mesothelioma patients.

    abstract：:Invariant natural killer T (iNKT) cells are a distinct subset of human T cells, which expresses an invariant T cell receptor Vα24 Jα18 and recognizes glycolipid antigens in the context of CD1d molecules. iNKT cells exert pivotal regulatory roles in many immune responses, including antitumor immune responses. Alteratio...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.20553

    authors： Altomare E,Fallarini S,Biaggi G,Gattoni E,Botta M,Lombardi G

    更新日期：2012-07-01 00:00:00

  • Cancer mortality trends between 1988 and 2009 in the metropolitan area of Naples and Caserta, Southern Italy: Results from a joinpoint regression analysis.

    abstract：:Mortality data by geographic area and trend-based surveillance are particularly relevant in orienting public health decisions targeting specific populations. We analyzed overall and site-specific cancer mortality between 1988 and 2009 in the metropolitan area of Naples and Caserta in southern Italy. Age-standardized m...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.26425

    authors： Crispo A,Barba M,Malvezzi M,Arpino G,Grimaldi M,Rosso T,Esposito E,Sergi D,Ciliberto G,Giordano A,Montella M

    更新日期：2013-12-01 00:00:00

  • Serial endoscopy in azoxymethane treated mice using ultra-high resolution optical coherence tomography.

    abstract：PURPOSE:Optical coherence tomography (OCT) is a minimally invasive, depth-resolved imaging tool that can be implemented in a small diameter endoscope for imaging mouse models of colorectal cancer (CRC). In this study, we utilized ultrahigh resolution (UHR) OCT to serially image the lower colon of azoxymethane (AOM) tre...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.6.11.4852

    authors： Hariri LP,Qiu Z,Tumlinson AR,Besselsen DG,Gerner EW,Ignatenko NA,Povazay B,Hermann B,Sattmann H,McNally J,Unterhuber A,Drexler W,Barton JK

    更新日期：2007-11-01 00:00:00

  • The role of apoptosis in cancer cell survival and therapeutic outcome.

    abstract：:A number of discoveries have clarified the molecular mechanism of apoptosis, thus clarifying the link between apoptosis and therapeutic outcome. Even though apoptosis is thought to play a major role in anticancer therapy, the clinical relevance of induction of apoptosis remains uncertain, particularly in solid tumors....

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.5.11.3456

    authors： Kim R,Emi M,Tanabe K

    更新日期：2006-11-01 00:00:00

  • Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin.

    abstract：:The efficient treatment of lung carcinomas with chemotherapeutics still poses a challenge for anti-cancer therapy. Since stromal cells of the tumor may alter the responsiveness of tumor cells to chemotherapeutics, we studied the impact of lung fibroblasts (WI-38) on the chemotherapy-induced death of non-small cell lun...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.7.8.6264

    authors： Bartling B,Hofmann HS,Silber RE,Simm A

    更新日期：2008-08-01 00:00:00

  • Triggering of toll-like receptor-4 in human multiple myeloma cells promotes proliferation and alters cell responses to immune and chemotherapy drug attack.

    abstract：:Multiple myeloma (MM) is an incurable B-cell malignancy characterized by accumulation of malignant plasma cells in the bone marrow and by recurrent or persistent infections. Toll-like receptors (TLRs) are essential in the host defense against infections. The aim of this study was to investigate TLR initiated responses...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.11.1.13878

    authors： Bao H,Lu P,Li Y,Wang L,Li H,He D,Yang Y,Zhao Y,Yang L,Wang M,Yi Q,Cai Z

    更新日期：2011-01-01 00:00:00

  • Colorectal cancer: new advances in immunotherapy.

    abstract：:Colorectal cancer remains the second leading cause of cancer-related mortality in the United States. Although surgical resection is still the primary treatment for colorectal cancer, in recent years, there has been a remarkable progress in the development of new therapies to treat colorectal cancer. Response rates hav...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.6.1.3672

    authors： Cubas R,Li M,Chen C,Yao Q

    更新日期：2007-01-01 00:00:00

  • 5-hydroxymethylcytosine: a new insight into epigenetics in cancer.

    abstract：:DNA methylation at the 5 position of cytosine (5-mC) has emerged as a key epigenetic marker that plays essential roles in various biological and pathological processes. 5-mC can be converted to 5-hydroxymethylcytosine (5-hmC) by the ten-eleven translocation (TET) family proteins, which is now widely recognized as the ...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,评审

    doi：10.4161/cbt.27144

    authors： Ye C,Li L

    更新日期：2014-01-01 00:00:00

  • Comparison of genetic changes between interphase and metaphase nuclei in monitoring CML and APL treatment using DC-FISH technique.

    abstract：:In leukemias, the monitoring techniques on the response after the treatment have clinical importance for evaluating new therapeutic approaches and identifying the risk of relapse. In this study, genetic changes before and after chemotherapy in interphase and metaphase nuclei of bone morrow of adults with provisional d...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.3.9.1039

    authors： Yakut T,Ali R,Egeli U,Ozkalemkas F,Ercan I,Ozçelik T,Ozkocaman V,Yigit B,Tunali A

    更新日期：2004-09-01 00:00:00

  • c-Myc modulation: a key role in melanoma drug response.

    abstract：:Understanding molecular mechanisms involved in melanoma resistance to drugs is a big challenge. Experimental evidences suggested a correlation between mutational status in B-RAF and melanoma cell susceptibility to drugs, such as paclitaxel, doxorubicin and temozolomide, which generate an accumulation of hydrogen perox...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2015.1030546

    authors： Fico A,Alfano D,Valentino A,Vasta V,Cavalcanti E,Travali S,Patriarca EJ,Caputo E

    更新日期：2015-01-01 00:00:00

  • Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402.

    abstract：:This study aimed to investigate the inhibitory effect of tyroservaltide (YSV) on the human hepatocarcinoma BEL-7402 transplanted into nude mice and to explore its possible anti-tumor mechanism. Nude mice bearing xenografts of the human BEL-7402 hepatoma were given daily i.p. injections of YSV or saline (as a control) ...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.4161/cbt.4.9.1968

    authors： Jia J,Lu R,Qiu S,Li H,Che X,Zhao P,Jin M,Yang H,Lin G,Yao Z

    更新日期：2005-09-01 00:00:00

  • MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.

    abstract：:Ovarian cancer (OC) is xenogeneic that is influenced by many generated factors related to epigenetic factors to accelerate tumor metastasis. This study was conducted with the objective of investigating the effect of microRNA-23a-3p (miR-23a) on the biological characteristics of OC stem cells by targeting discs large h...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章

    doi：10.1080/15384047.2019.1579960

    authors： Zhuang RJ,Bai XX,Liu W

    更新日期：2019-01-01 00:00:00

  • Somatostatin receptor scintigraphy screening in advanced hepatocarcinoma: A multi-center French study.

    abstract：BACKGROUND:Somatostatin receptor scintigraphy (SRS) has been reported for receptor (SSTR) screening in advanced hepatocarcinoma (aHC) prior to somatostatin analogue treatment. AIMS:To evaluate SSTR screening with SRS in aHC patients. RESULTS:Seventy aHC patients (63 men) aged 65 +/- 11 y were included, with alcohol, ...

    journal_title：Cancer biology & therapy

    pub_type： 杂志文章,多中心研究

    doi：10.4161/cbt.8.21.9737

    authors： Nguyen-Khac E,Ollivier I,Aparicio T,Moullart V,Hugentobler A,Lebtahi R,Lobry C,Susini C,Duhamel C,Hommel S,Cadranel JF,Joly JP,Barbare JC,Tramier B,Dupas JL

    更新日期：2009-11-01 00:00:00